Several ISGs have been shown to decrease HCV replication by affecting virus infection (Mx, TRIM, IFITM, CH25H), viral RNA translation, replication, stability (OAS, IFIT, GBP1), or virus packaging and release (tetherin/BST2, viperin) [23,24]. This evidence concerns the gene BST2 and viral infectious disease.